InMed Pharmaceuticals Inc. (INM)
NASDAQ: INM · Real-Time Price · USD
2.160
+0.010 (0.47%)
Oct 21, 2025, 11:59 AM EDT - Market open
InMed Pharmaceuticals Market Cap
InMed Pharmaceuticals has a market cap or net worth of $5.15 million as of October 21, 2025. Its market cap has increased by 77.58% in one year.
Market Cap
5.15M
Enterprise Value
-5.25M
1-Year Change
77.58%
Ranking
Category
Stock Price
$2.16
Market Cap Chart
Since November 16, 2020, InMed Pharmaceuticals's market cap has decreased from $26.00M to $5.15M, a decrease of -80.19%. That is a compound annual growth rate of -28.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 20, 2025 | 5.10M | 50.00% |
| Dec 31, 2024 | 3.40M | 54.55% |
| Dec 29, 2023 | 2.20M | 15.79% |
| Dec 30, 2022 | 1.90M | -89.73% |
| Dec 31, 2021 | 18.50M | -19.57% |
| Dec 31, 2020 | 23.00M | -11.54% |
| Nov 16, 2020 | 26.00M | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 726.23B |
| Johnson & Johnson | 466.54B |
| AbbVie | 409.95B |
| UnitedHealth Group | 330.10B |
| AstraZeneca | 261.56B |
| Novartis AG | 254.74B |
| Novo Nordisk | 249.65B |
| Abbott Laboratories | 225.41B |